Table of Contents
This BCC Research report provides detailed market and industry analyses to help readers quantify and qualify the global market for induced pluripotent stem cells (iPSCs). Important trends of the field and market segments are identified, and market sizes and sales forecasts by segmented markets are provided through 2018. Information is presented with a specific focus on the various market segments, including product-type-based, product-function-based, application-based, geography-based and technological-method-based.
Use this report to:
- Receive comprehensive and up-to-date background on the marketplaces associated with the induced pluripotent stem cells.
- Learn about the various market segments, including product-type-based, product-function-based, application-based, geography-based and technological-method-based.
- Receive research and market trends by analyzing the funding, patent publications and sales trends of major players in the field.
- Receive profiles of leading companies in the industry.
- The global market for induced pluripotent stem cells (iPSCs) was estimated to total $853 million in 2012, and close to $1.2 billion in 2013, averaging 40% growth. The market is expected to reach $2.9 billion in 2018, an estimated compound annual growth rate (CAGR) of 19.7% for the five-year period 2013 to 2018.
- The U.S. market was valued at $605 million in 2013 and is expected to reach nearly $1.5 billion by 2018, a CAGR of 19.4% from 2013 to 2018.
- The Asia-Pacific market was valued at $260 million in 2013 and will experience the fastest growth among all regional markets with a five-year CAGR of 22% to reach $703 million by 2018.
STUDY GOALS AND OBJECTIVES
The aim of this report is to provide detailed market and industry analyses to help readers quantify and qualify the global market for induced pluripotent stem cells
(iPSCs). Important trends of the field and market segments are identified, and market sizes and sales forecasts by segmented markets are provided through 2018.
This report focuses on the market side rather than the technical side. The detailed market segmentation, market shares, major drivers, trend analysis and forecasts for
the entire iPSCs market are analyzed.
REASONS FOR DOING THIS STUDY
Detailed market and industry analysis for the iPSCs market is needed. As a breakthrough technology recognized by 2012 Nobel Physiology and Medicine Prize,
iPSCs technology may bring a revolutionary change to modern medicine. Great opportunities always exist with high risks, but the detailed analysis and forecasts of the
iPSC market can provide useful information for all management levels to help make strategic decisions in related areas. iPSC-related products are forming an emerging market despite the fact that iPSC clinical applications are still under development. The potential scope of the iPSC market is becoming clear, and it is appropriate to review the emerging market, see thecurrent size and share of each segment, evaluate the market trends and look to its future.
This report is designed to satisfy the information needs of various individuals involved in the biological research, pharmaceutical and regenerative medicine marketplaces,
including company senior management executives seeking to base their strategic decisions on the best available information on market forces and trends. It is also
aimed at managers and executives in marketing, research, planning and sales departments who need readable, comprehensive and up-to-date background on the
marketplaces associated with the induced pluripotent stem cells with which they are operating.
This report was prepared as a study of the global market for induced pluripotent stem cells. Information is presented with a specific focus on the various market segments,
including product-type-based, product-function-based, application-based, geography-based and technological-method-based. The detailed segmentation is to
provide a deep profiling of the global iPSCs market based on which the market forecasts are made.
This study will be of significant interest to academic institutions, hospitals, biotech and pharmaceutical companies, biopharmaceutical researchers, marketing executives from pharmaceutical and biotech companies, contract research organizations, biologists, chemists, physicians, pharmaceutical directors, product managers and representatives, and all manner of institutional directors from either public or private entities. It will also be of interest to investment bankers in the biotechnology and pharmaceutical sectors, insurance executives and life sciences product marketing managers.
SCOPE OF REPORT
This study is focused on the market side of iPSCs rather than its technical side. Different market segments for this emerging market are covered. For example,
application-based market segments include academic research, drug development and toxicity testing, and regenerative medicine; product function-based market segments
include molecular and cellular engineering, cellular reprogramming, cell culture, cell differentiation, and cell analysis; iPSC-derived cell-type-based market segments include
cardiomyocytes, hepatocytes, neurons, endothelia cells, and other cell types; geography-based market segments include the U.S., Europe, Asia-Pacific and Rest of
World. Research and market trends are also analyzed by analyzing the funding, patent publications and sales trends of major players in the field.
Both primary and secondary research methodologies were used to prepare this study. Primary research includes interviews with leading individuals in stem cell companies
and industry associations. Primary sources of published data include company annual reports, SEC filings, and government and industry publications. Secondary sources
consist of literature searches, industry journals and other commercial publications. Data for market estimates and forecasts are pooled from a range of sources that were
critically assessed by BCC Research.
Get Industry Insights. Simply.
Talk to Ahmad
+1 718 618 4302
The global stem cell therapy market is estimated to grow at a CAGR of 11.0% during 2016 to 2021 to reach USD 145.8 million by 2021. Growth in the global stem cell therapy market is driven by factors such ...
The global human embryonic stem cells (hESCs) market is anticipated to reach USD 1.06 billion by 2025, according to a new report by Grand View Research, Inc. Application of hESCs as a promising donor source ...
Stem cell is an undifferentiated cell that has potential to develop into any type of cell in the body. A stem cell bank stores these stem cells for future use. The stem cell banking market accounted to ...